Associate Professor of Obstetrics & Gynecology
Research summary: Dr. Romero's research group evaluates the metabolic changes that occur in tumors and the tumor microenvironment and uses this knowledge to identify novel treatments. For cancer therapeutic development, Dr. Romero focuses on drugs that are already FDA approved for non-cancer indications and determines if they have protective effects in gynecologic cancers. Using this approach, her group has made significant progress with testing statins and metformin as potential metabolically-targeted therapeutics for gynecologic cancers.
View a partial list of Dr. Romero's publications through the National Library of Medicine's PubMed online database